Paul Sondel, MD, PhD, Awarded ICTR Novel Methods Pilot Grant

Paul Sondel, MD, PhD, was recently awarded a 1-yr, $50,000 Novel Methods Pilot award for his grant entitled, "Murine cancer models for testing in situ vaccination strategies". This grant from the UW Institute for Clinical and Translational Research (ICTR) will allow him to develop and characterize murine models of metastatic disease as a platform for preclinical testing of in situ tumor vaccination strategies. This work will provide insight on the interaction between metastatic sites of disease and the local and systemic response to in situ tumor vaccination, and the mouse models developed in this work will provide a critical platform for future testing of these strategies.